The Repair Stem Cells Institute Invites Participation in a Unique Study of a Stem Cell Treatment for Type 2 Diabetes

Dallas, TX (PRWEB) March 20, 2014

The Repair Stem Cells Institute (RSCI) -- -- is pleased to announce that it will assist interested patients to take part in a patient-sponsored research study based in the United States for the treatment of Type2 Diabetes with adult stem cells. The study, which meets current FDA guidelines, will be conducted during April 2014.

The study is being conducted by the U.S. based company Bioheart which has assembled teams of doctors and specialists specially trained in stem cell treatments. Based on previous treatment of Type 2 diabetes with autologous (the patients own) stem cells, it is estimated that two-thirds of participants will experience a significant quality of life improvement and symptoms reduction.

Type 2 diabetes makes up about 90% of cases of diabetes. Rates of type 2 diabetes have increased markedly since 1960. Today there are approximately 50 million people suffering from the disease compared to 15 million in 1985.

In a recent interview, RSCI founder and Chairman Don Margolis stated, With stem cell treatment rapidly coming to the forefront of 21st Century medicine, we are pleased that Type 2 Diabetes is among the many chronic conditions that are treatable with adult stem cells rather than potentially risky surgery, dangerous transplants, and toxic drugs.


Patients suffering from Type 2 diabetes who are cancer-free can apply to participate.

What will happen?

The 4-part procedure will be done in a participating doctors office as a point-of-care out-patient.

1.Adipose Harvest: During a 3 to 5 hour visit to the doctors office, a mini-liposuction on your stomach will extract a small amount of tummy fat containing tens of millions of adipose stem cells. 2.Laboratory Processing: The extracted stem cells will be isolated, analyzed, cleaned and concentrated. 3.Stem Cell Implantation: Up to 60 million stem cells will be transplanted intravenously, usually into your arm. Because these are the patients own cells, the risk of rejection is non-existent. 4.Postoperative Care: Normally, patients can leave shortly after implantation. RSCI will check on your progress monthly by telephone for the first year after stem cells.

View original post here:
The Repair Stem Cells Institute Invites Participation in a Unique Study of a Stem Cell Treatment for Type 2 Diabetes

Related Post